Literature DB >> 3180347

Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells.

J C Kirchheimer1, J Wojta, G Christ, G Hienert, B R Binder.   

Abstract

Primary cultures of renal cell carcinomas and of the corresponding normal adjacent kidney tissue from 6 patients were analyzed for the effects of exogenously added urokinase-type plasminogen activator on cell proliferation as compared to the effects of tissue type plasminogen activator, plasmin and dihydrocortisone. Cell proliferation was studied over a period of up to 5 days by measuring 3H-thymidine incorporation as well as cell viability and cell count; conditioned media of the cultures were also analyzed for their plasminogen activator and plasminogen activator inhibitor content. Addition of urokinase stimulated cell proliferation in a time and dose dependent fashion; after 3 days 3H-thymidine incorporation was significantly increased in malignant renal cells (188.3 +/- 28.7%), while it reached in normal renal cells approximately 130% of the 3H-thymidine incorporation of untreated cultures. Tissue-type plasminogen activator had no effect and plasmin decreased cell proliferation slightly while dihydrocortisone inhibited cell proliferation significantly (34.1 +/- 4.9%) in malignant cells. It is concluded that urokinase-type plasminogen activator itself exhibits a mitogenic effect also on primary cultures of renal cell carcinomas.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3180347     DOI: 10.1093/carcin/9.11.2121

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  5 in total

1.  Functional inhibition of endogenously produced urokinase decreases cell proliferation in a human melanoma cell line.

Authors:  J C Kirchheimer; J Wojta; G Christ; B R Binder
Journal:  Proc Natl Acad Sci U S A       Date:  1989-07       Impact factor: 11.205

2.  Autocrine regulation of growth stimulation in human epithelial ovarian carcinoma by serine-proteinase-catalysed release of the urinary-type-plasminogen-activator N-terminal fragment.

Authors:  D A Fishman; A Kearns; S Larsh; J J Enghild; M S Stack
Journal:  Biochem J       Date:  1999-08-01       Impact factor: 3.857

Review 3.  The plasminogen-plasmin system in malignancy.

Authors:  H C Kwaan
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

4.  Protein C inhibitor is expressed in tubular cells of human kidney.

Authors:  K P Radtke; J A Fernández; J S Greengard; W W Tang; C B Wilson; D J Loskutoff; I Scharrer; J H Griffin
Journal:  J Clin Invest       Date:  1994-11       Impact factor: 14.808

5.  Overexpression of urokinase-type plasminogen activator in human gastric cancer cell line (AGS) induces tumorigenicity in severe combined immunodeficient mice.

Authors:  Yang-Kyu Choi; Byung-Il Yoon; Yoon-Hoh Kook; Young-Suk Won; Jin-Hyun Kim; Chul-Ho Lee; Byung-Hwa Hyun; Goo-Taeg Oh; John Sipley; Dae-Yong Kim
Journal:  Jpn J Cancer Res       Date:  2002-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.